BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7103956)

  • 1. Limitations on the metyrapone assay for the major phenobarbital inducible form of cytochrome P-450.
    Ivanetich KM; Costa AK; Brittain T
    Biochem Biophys Res Commun; 1982 Apr; 105(4):1322-6. PubMed ID: 7103956
    [No Abstract]   [Full Text] [Related]  

  • 2. Complexes of cytochrome P450 with metyrapone. A convenient method for the quantitative analysis of phenobarbital-inducible cytochrome P450 in rat liver microsomes.
    Mitani F; Shephard EA; Phillips IR; Rabin BR
    FEBS Lett; 1982 Nov; 148(2):302-6. PubMed ID: 7152025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metyrapone interaction with hepatic microsomal cytochrome P-450 from rats treated with phenobarbital.
    Hildebrandt AG; Leibman KC; Estabrook RW
    Biochem Biophys Res Commun; 1969 Oct; 37(3):477-85. PubMed ID: 5349284
    [No Abstract]   [Full Text] [Related]  

  • 4. Active centers of microsomal cytochrome P-450 determined with metyrapone by mutural depletion system kinetics.
    Roots I; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):39-52. PubMed ID: 4267597
    [No Abstract]   [Full Text] [Related]  

  • 5. Metyrapone - reduced cytochrome P-450 complex: a specific method for the determination of the phenobarbital inducible form of rat hepatic microsomal cytochrome P-450.
    Luu-The V; Cumps J; Dumont P
    Biochem Biophys Res Commun; 1980 Apr; 93(3):776-81. PubMed ID: 7387674
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-competitive and competitive inhibition of mixed function oxidase in rat liver microsomes by metyrapone.
    Roots I; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):27-38. PubMed ID: 4350469
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytochrome P-450 ligands: metyrapone revisited.
    Liu Z; Franklin MR
    Arch Biochem Biophys; 1985 Sep; 241(2):397-402. PubMed ID: 4037796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of phenobarbital-induced cytochrome P-450 in rat hepatic microsomes using an enzyme-linked immunosorbent assay.
    Seidel SL; Shawver LK; Shires TK
    Arch Biochem Biophys; 1984 Mar; 229(2):519-31. PubMed ID: 6703710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pyridine and some pyridine derivatives on spectral properties of reduced microsomes and on microsomal drug metabolizing activity.
    Jonen HG; Hüthwohl B; Kahl R; Kahl GF
    Biochem Pharmacol; 1974 Apr; 23(8):1319-29. PubMed ID: 4824776
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbon tetrachloride-altered binding of carbon monoxide to reduced cytochrome P-450 in phenobarbital microsomes.
    Bidlack WR; Advani SV; Andresen JW
    Biochem Med; 1980 Apr; 23(2):205-8. PubMed ID: 7396889
    [No Abstract]   [Full Text] [Related]  

  • 11. The monooxygenation of N-heptane by rat liver microsomes.
    Frommer U; Ullrich V; Staudinger H; Orrenius S
    Biochim Biophys Acta; 1972 Dec; 280(4):487-94. PubMed ID: 4405405
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of phenobarbital and 3-methylcholanthrene administration in vivo and isooctane extraction in vitro on metyrapone binding to reduced cytochrome P-450.
    Kahl R; Jonen HG; Kahl GF
    Biochem Pharmacol; 1974 Aug; 23(16):2305-14. PubMed ID: 4851681
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of the Ah locus with specific changes in metyrapone and ethylisocyanide binding to mouse liver microsomes.
    Kahl GF; Kahl R; Kumaki K; Nebert DW
    J Biol Chem; 1976 Sep; 251(17):5397-407. PubMed ID: 8465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the drug metabolising ability of rat intestinal mucosal microsomes with that of liver.
    Shirkey RS; Chakraborty J; Bridges JW
    Biochem Pharmacol; 1979 Sep; 28(18):2835-9. PubMed ID: 497032
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of aromatic nitro compounds with reduced hepatic microsomal cytochrome P-450.
    Sternson LA; Gammans RE
    Drug Metab Dispos; 1975; 3(4):266-74. PubMed ID: 240656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of carbon tetrachloride toxicity and cirrhosis on substrate binding to rat hepatic microsomal cytochrome P-450.
    Murray M; Farrell GC
    Biochem Pharmacol; 1984 Feb; 33(4):687-9. PubMed ID: 6704188
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of cytochrome P-450 in the N-oxidation of individual amines.
    Uehleke H
    Drug Metab Dispos; 1973; 1(1):299-313. PubMed ID: 4149397
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation and binding of carbanions by cytochrome P-450 of liver microsomes.
    Ullrich V; Schnabel KH
    Drug Metab Dispos; 1973; 1(1):176-83. PubMed ID: 4149380
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing the inhibitory effect of carbon monoxide on cytochrome P-450-catalyzed mixed function oxidation reactions.
    Estabrook RW; Franklin MR; Hildebrandt AG
    Ann N Y Acad Sci; 1970 Oct; 174(1):218-32. PubMed ID: 4332408
    [No Abstract]   [Full Text] [Related]  

  • 20. The heme protein P-450 in oxygen activation: carbon monoxide inhibition and photochemical action spectroscopy as tools to study its catalytic role.
    Schleyer H; Hamill S; Cooper DY; Rosenthal O
    Adv Exp Med Biol; 1981; 136 Pt A():119-43. PubMed ID: 7344454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.